Skip to content
VitroSciences

Fundamentals

Lyophilization: what freeze-drying does to a peptide

Updated August 26, 2026

A lyophilized peptide is the dry solid left when an aqueous solution of the peptide is frozen and the ice removed by sublimation under vacuum. It is supplied dry because water is a reagent in several of the routes by which a peptide degrades. What remains is the peptide, its counter-ion, any excipients, and a few percent of water that never froze.

What freeze-drying does

Lyophilization runs in three stages: freezing, primary drying, and secondary drying. They remove different things, and freezing removes none.

Freezing converts the solvent to ice. Growing ice crystals exclude dissolved solutes from the lattice, so the peptide, its counter-ion and any excipients are pushed into a shrinking unfrozen fraction that grows more concentrated until it crystallizes or stops flowing as a glass. Ice crystal size is settled here and nothing later changes it: fast cooling nucleates many small crystals and gives a fine-pored solid, slow cooling gives fewer and larger crystals and a more open one that dries faster.

Primary drying removes the ice by sublimation, the phase change from solid directly to vapor with no liquid stage in between. It works because the chamber pressure is held below the triple-point pressure of water. The triple point, 0.01 °C and 611 Pa, is the one condition at which solid, liquid and vapor coexist; below that pressure liquid water is not stable at any temperature, so ice supplied with heat can only become vapor. Working chambers run at 7–27 Pa (50–200 mTorr). Shelf heat supplies the enthalpy of sublimation, the vapor freezes onto a cold condenser, and the solid stays cold because sublimation is endothermic. Sublimation is not evaporation: nothing in the vial is ever liquid, so nothing flows, and the solid keeps the shape the frozen solution had.

Secondary drying removes the water that sublimation does not: molecules sorbed to the solid surfaces and dissolved in the amorphous, non-crystalline phase, which were never part of the ice. It leaves by desorption, driven by raising the shelf temperature, commonly to 20–40 °C, with the vacuum held. This stage sets the residual moisture, the water content a certificate reports.

Stage → what happens to the water → what the stage settles
StageWaterSettles
FreezingConverted to ice; none removedIce crystal size, and so the pore structure of the finished solid
Primary dryingIce removed by sublimation under vacuumMost of the total water; the shape the solid holds
Secondary dryingSorbed and dissolved water removed by desorptionThe water content reported at release

Why the cake looks the way it does

The cake is what the ice left behind. Ice crystals occupy a volume in the frozen solution, and solutes are excluded into the spaces between them. When those crystals sublime, the volume they held becomes void and the excluded solids remain as the walls around it. A cake is therefore a void structure whose pores have the shape of the crystals that filled them, which is why a well-formed one stands to roughly the height the liquid did and dissolves quickly.

Total solids, and what happens in transit, decide which of three forms that structure takes, and all three are normal.

Form in the vial → why it formed
FormWhy
Coherent puckEnough total solids to build a self-supporting matrix across the fill volume
Thin film or ring on the glassToo little solid to support a matrix, so the residue dries onto the surface
Loose powder at the baseA fragile low-solids cake fragmented by vibration in transit

A film rather than a puck is not a defective vial. Vitro’s certificate tests Appearance by method Visual against a specification of a white to off-white lyophilized powder, and the specimen lot’s result is Conforms. That row is a qualitative check on color and form, not a requirement for an intact puck. A few milligrams of solid can be difficult to see at all. What a cake does once diluent reaches it is covered in reconstituting lyophilized peptides.

Excipients and bulking agents

An excipient is any component of a formulation other than the substance being formulated; a bulking agent is one added to give the freeze-dried solid mass and structure. Mannitol and trehalose are the two in common use.

Milligram-scale fills need bulk because a self-supporting cake requires a minimum quantity of solid. Around 2 % w/v total solids is a commonly cited practical minimum; 5 mg of peptide in a 2 mL fill is 0.25 % w/v, roughly an order of magnitude short. Where a bulking agent is used it makes up the difference; without one, a few milligrams of solid may form no visible cake at all.

Bulking agent → behavior on freezing → consequence
AgentOn freezingConsequence
MannitolCrystallizes, especially if the cycle includes an annealing hold, a period held above the final freezing temperature to let crystals growMechanically strong, well-formed cake; being crystalline it does little to stabilize an amorphous, non-crystalline solute, and its hemihydrate can release water during storage
TrehaloseStays amorphous and forms a glassBeing non-reducing, it does not react with peptide amine groups as a reducing sugar such as lactose or glucose would; its freeze-concentrate glass transition is higher than sucrose’s, so a warmer primary drying is tolerated

Excipient mass is part of what the vial holds and none of it is peptide. Vitro’s certificate carries Net content / vial in the header as a declared figure and Net content in the results table by gravimetry; the balance weighs the whole solid. Two composition rows let part of it be subtracted: Water content by Karl Fischer and Counter-ion (acetate) by HPLC. On the specimen certificate, 50.3 mg weighed at 5.1 % water and 6.8 % counter-ion leaves about 44.3 mg of peptide.

When a cake looks wrong

A cake is the porous solid left in the vial after freeze-drying. Collapse, meltback and shrinkage are departures from a well-formed one, and each indicates something different.

Collapse is the amorphous (non-crystalline) matrix losing rigidity during primary drying, because the product went above its collapse temperature, at which the freeze-concentrated solid begins to flow. Pores close before drying is finished, leaving a dense, shrunken, often glassy residue occupying much less than the fill volume. A collapsed structure has far less internal surface, so secondary drying reaches less of it; collapse and an elevated water content usually appear together, and dissolution takes longer.

Meltback means liquid existed at some point in the cycle. The product went above its eutectic melting temperature, the temperature at which a crystalline solute and ice melt together, or melted outright, and material that had been frozen redissolved and then dried from the liquid state. It leaves a dense glassy plug or a hard residue at the base rather than a solid standing to the fill height, and it indicates the cycle rather than storage.

Shrinkage is the solid retracting from the glass. Slight retraction is common in amorphous, sugar-rich formulations and often present at release. Pronounced shrinkage, slumping, a glassy sheen or discoloration in a vial that passed its appearance check at release indicates storage or transit instead: a lyophilized solid is hygroscopic, so water drawn in from the air lowers its glass transition temperature, and a warm excursion then takes the matrix through that transition.

Observation → what it suggests → where it arose
ObservationSuggestsArose in
Dense, glassy, well below fill heightCollapse above the collapse temperatureThe drying cycle
Hard plug or puddle-shaped residue at the baseMeltback; liquid present during the cycleThe drying cycle
Slight gap between solid and glassOrdinary shrinkage of an amorphous cakeEither; often present at release
Slumped, glassy or discolored on arrivalMoisture uptake or a thermal excursionStorage or transit

Appearance is not an assay. It is one visual row on a certificate and reports nothing quantitative: a collapsed cake can still meet its purity specification, and a well-formed one can fail it. The numbers come from instruments, RP-HPLC reporting purity as area percent at 220 nm and ESI-MS confirming identity, both covered in peptide purity by HPLC and MS, and Karl Fischer for water. A vial whose appearance no longer matches the description its lot passed on is grounds to re-analyze it; its lot number pulls that certificate at verify.

Residual moisture

Residual moisture is the water still in the solid once freeze-drying is finished: molecules sorbed to the solid surfaces and dissolved in the amorphous, non-crystalline phase, never part of the ice and so not removable by sublimation. Secondary drying, desorption under vacuum at a raised shelf temperature, removes most of it; what survives is measured per lot.

Vitro’s certificates report it as Water content, method Karl Fischer, with the methods note specifying the coulometric variant. On the specimen certificate the result is 5.1 % against a specification of ≤ 8.0 %. Karl Fischer titrates water specifically, which is why it is preferred to loss on drying, which weighs everything volatile, residual solvent included.

It is measured because water sets the rate of the chemistry that limits how long a dry peptide keeps. Water is the reagent in hydrolysis of the backbone amide bonds and in deamidation, the hydrolysis of the asparagine and glutamine side-chain amides. Water taken up into an amorphous glass also plasticises it, lowering the glass transition temperature; a matrix nearer that transition has the molecular mobility those reactions need. Which residues each route acts on is set out in storing research peptides.

The specification is an upper limit for the material rather than a target of zero: for some amorphous solids, driving water very low destabilizes rather than stabilizes them. The reported figure is a snapshot taken at release. Nothing in normal handling drives water back out of a vial, and opening one cold admits humid air that a hygroscopic solid draws in and holds. That is why a vial should reach room temperature sealed before it is opened.

For laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure, or prevent any disease.